SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Top Headlines

Vitamin B6 deficiency linked to cognitive decline: Study

Low vitamin B6 intake may contribute to cognitive decline in older adults, while other B vitamins do not show the same effects, according to a new follow-up study in Northern Ireland.

Those with lower vitamin B6 levels 'were 3.5 times more likely' to have a greater rate of cognitive decline...' ©iStock

Cry baby: Infant tears reveal nutrient deficiencies

Tears have been suggested as a reliable indicator of health as researchers have found the nutrient profile of this biofluid to be similar to blood, which may enhance the speed of deficiency diagnoses.

Algae omega-3 & plant sterols seek EU approval

Canadian and Chinese suppliers have applied for algae omega-3 and plant sterol approval under ‘substantial equivalence’ EU novel food rules.

News in brief

Kappa buys European distributor

Norwegian vitamin K specialist Kappa Bioscience has acquired its long-time European distributor, ppm.Ingredients KG (PPM) and boosted its offerings.

Probiotics may reverse damage of generational stress

Taking male rat pups away from their mothers can produce detrimental effects in those rats when they mature, including mental illness, and these effects can then be passed on to the next generation. A new study suggests that probiotics can help reverse this transgenerational damage.

Meta-analysis supports pomegranate juice’s blood pressure benefits

A comprehensive meta-analysis of data from eight RCTs supported a role for pomegranate juice in a heart-healthy diet.

Lotte’s probiotic chocolate success highlights functional potential in Japan

Functional chocolate is poised to contribute to market growth in Japan based on the success of Lotte’s Sweet Days chocolate, says market analyst Canadean.

Probiotics and Alzheimer’s: Personalised nutrition tipped to become crucial area of treatment research

Modulation of gut microbiota through personalised diet or probiotic intervention will increasingly become a key focus for treating brain disorders including Alzheimer’s Disease, Chinese academics have concluded in a new review.